AMetIPNCT06309680
Accuracy of Metagenomic Blood Sampling to Identify Pathogen in Infective Endocarditis Patients
StatusActive, Not Recruiting
PhaseNot specified
Primary completion (estimated)
At risk: Primary completion moved 12 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 5 versions: 5 with changes below. See every version on ClinicalTrials.gov ↗
Notable Primary and study completion pushed from Oct 1, 2026 to Oct 1, 2027 Show 5 more changesShow less
- Eligibility criteria expanded, about 5 words
- Secondary endpoints: details revised at 2 of 3 entries
- Study description revised
- Site details revised
- Collaborators: details revised at 1 of 2 entries
- Notable Primary and study completion dates: Oct 1, 2025 to Oct 1, 2026
- Trial status: Recruiting to Active, Not Recruiting
- Site details revised
- Minor Primary and study completion dates: Jul 31, 2025 to Oct 1, 2025v3
- Minor Secondary endpoints revised (3)
- Primary endpoint revised
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Diagnostic accuracy of CMg in blood
Timeframe: 3 years
Secondary (3)
To evaluate the results of Nanopore CMg in identifying the causative organism in patients with BCNIE
1. Optimal timing of blood sampling
3. Metagenomic Techniques
Sites
1 site in 1 country
- St Bartholomew's Hospital. West SmithfieldLondon, United Kingdom